At a glance
ClinicalIndex Comparison RecordN/ACompleted· 376 enrolled
Drug / intervention
Redesigned Purevision Contact Lens +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study to Evaluate the Product Performance of Two Different Designs of Bausch & Lomb PureVision® Contact Lenses
In Brief
A clinical study evaluating Redesigned Purevision Contact Lens and PureVision Contact Lens for Myopia. Completed, enrolled 376 participants across 1 site.
Detailed Summary
The objective of this one month study is to evaluate the product performance of a redesigned PureVision Contact Lens compared to the PureVision Contact Lens when worn on a daily wear basis by wearers of contact lenses.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2010
First PostedMay 2010
Primary CompletionJun 2010
Study CompletionJul 2010
TodayJul 2026
First PostedMay 6, 2010
Enrollment StartMay 1, 2010
Primary CompletionJun 1, 2010
Study CompletionJul 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 16.2 years ago
Interventions
Redesigned Purevision Contact Lensdevice
Lenses will be dispensed at screening visit, subjects will wear lenses on a daily wear basis for one month.
PureVision Contact Lensdevice
Lenses will be dispensed at screening visit, subjects will wear lenses on a daily wear basis for one month.